3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
235
Lymphoma
160
Leukemia
109
Burkitt Lymphoma
91
Lymphoma, Non-Hodgkin
85
Lymphoma, Large B-Cell, Diffuse
80
Lymphoma, Mantle-Cell
70
Leukemia, Myeloid, Acute
53
Lymphoma, Follicular
49
Hodgkin Disease
44
Lymphoma, Large-Cell, Immunoblastic
37
Leukemia, Lymphocytic, Chronic, B-Cell
33
Recurrence
32
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Biphenotypic, Acute
24
Myelodysplastic Syndromes
23
Blast Crisis
19
Lymphoma, Large-Cell, Anaplastic
18
Lymphoma, B-Cell
18
Dendritic Cell Sarcoma, Interdigitating
17
Congenital Abnormalities
17
Leukemia, Myeloid, Accelerated Phase
16
Leukemia, Myelomonocytic, Chronic
15
Multiple Myeloma
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, T-Cell
11
Myeloproliferative Disorders
10
Anemia, Refractory, with Excess of Blasts
10
Neoplasms, Plasma Cell
9
Interventions
Doxorubicin
6
Vincristine
4
Dexrazoxane
4
Razoxane
3
Radiotherapy
2
Prednisone
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Exercise
2
Etoposide
2
Cyclophosphamide
2
Bleomycin
2
pegfilgrastim
1
hydrocortisone hemisuccinate
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Secondary Prevention
1
Rituximab
1
Pulse Wave Analysis
1
Prednisolone
1
Nebivolol
1
Methotrexate
1
Methods
1
Mercaptopurine
1
Leucovorin
1
Lenalidomide
1
Hydrocortisone
1
Electrocardiography
1
Echocardiography
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Cytarabine
×
Lymphoid
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled